Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Prepaid Assets (2016 - 2025)

Intellia Therapeutics (NTLA) has disclosed Prepaid Assets for 11 consecutive years, with $68.4 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 129.15% to $68.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.4 million through Dec 2025, up 129.15% year-over-year, with the annual reading at $68.4 million for FY2025, 129.15% up from the prior year.
  • Prepaid Assets for Q4 2025 was $68.4 million at Intellia Therapeutics, up from $59.8 million in the prior quarter.
  • The five-year high for Prepaid Assets was $68.4 million in Q4 2025, with the low at $14.0 million in Q3 2021.
  • Average Prepaid Assets over 5 years is $33.0 million, with a median of $26.8 million recorded in 2022.
  • The sharpest move saw Prepaid Assets soared 222.72% in 2021, then plummeted 52.41% in 2025.
  • Over 5 years, Prepaid Assets stood at $18.6 million in 2021, then grew by 9.81% to $20.4 million in 2022, then soared by 143.3% to $49.7 million in 2023, then tumbled by 39.92% to $29.8 million in 2024, then skyrocketed by 129.15% to $68.4 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $68.4 million, $59.8 million, and $36.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.